Lack of association between neuroleptic malignant syndrome and polymorphisms in the 5-HT(1A) and 5-HT(2A) receptor genes

American Journal of Psychiatry

Volumn 155, Issue 9, 1998, Pages 1275-1277

  Kawanishi, Chiaki ^a   Hanihara, Tokiji ^b   Shimoda, Yoshikazu ^b   Suzuki, Kyoko ^b   Sugiyama, Naoya ^b   Onishi, Hideki ^b   Miyakawa, Tomohiro ^b   Yamada, Yoshiteru ^b   Kosaka, Kenji ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HEREDITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEUROLEPTIC MALIGNANT SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM;

EID: 0031687155     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.9.1275     Document Type: Article

References (15)

1. Pope HG Jr, Keck PE Jr, McElroy SL: Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1986; 143:1227-1233
2. Itoh H, Ohtsuka N, Ogita K, Yagi G, Miura S, Koga Y: Malignant neuroleptic syndrome - its present status in Japan and clinical problems. Folia Psychiatr Jpn 1977; 31:565-576
3. Deuschl G, Oepen G, Hermle L: Neuroleptic malignant syndrome: observations on altered consciousness. Pharmacopsychiatry 1987; 20:168-170
4. Otani K, Horiuchi M, Kondo T, Kaneko S, Fukushima Y: Is the predisposition to neuroleptic malignant syndrome genetically transmitted? Br J Psychiatry 1991; 158:850-853
5. Lazarus AL, Moore KE, Spinner NB: Recurrent neuroleptic malignant syndrome associated with inv dup (15) and mental retardation. Clin Genet 1991; 39:65-67
6. Iwahashi K: CYP2D6 genotype and possible susceptibility to the neuroleptic malignant syndrome. Biol Psychiatry 1994; 36:781-782
7. 2 receptor gene in a patient with neuroleptic malignant syndrome. Am J Med Genet 1995; 60:228-230
8. Sternbach H: The serotonin syndrome. Am J Psychiatry 1991; 148:705-713
9. Heyland D, Sauve M: Neuroleptic malignant syndrome without the use of neuroleptics. Can Med Assoc J 1991; 145:817-819
10. Miyaoka H, Kamijima K: Encephalopathy during amitriptyline therapy: are neuroleptic syndrome and serotonin syndrome spectrum disorders? Int Clin Psychopharmacol 1995; 10: 265-267
11. Lam S, Shen Y, Nguyen T, Messier TL, Brann M, Comings D, George SR, O'Dowd BF: A serotonin receptor gene variant found in a Tourette's syndrome patient. Biochem Biophys Res Commun 1996; 219:853-858
12. 2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 1996; 97:614-619
13. Insel TR, Roy BF, Cohen RM, Murphy DL: Possible development of the serotonin syndrome in man. Am J Psychiatry 1982; 139:954-955
14. Goodwin GM, De Souza RJ, Green AR, Heal DJ: The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino) tetralin. Psychopharmacology (Berl) 1987; 91:506-511
15. Ames D, Wirshing WC: Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome - a possible link? (letter). JAMA 1993; 269:869